Detail |
Ctyoband |
LncRNAs |
miRNAs |
mRNAs |
FDR |
Disease |
 |
 | 2q32.1 | LINC01473 | hsa-miR-370-3p | MAP3K8 | 5.99E-12 | PRAD |       |
 | 2q32.1 | LINC01473 | hsa-miR-370-3p | HMGA2 | 6.67E-11 | THCA |       |
 | 2q32.1 | LINC01090 | hsa-miR-145-5p | FZD7 | 2.83E-9 | PAAD |       |
 | 2q32.1 | LINC01090 | hsa-miR-145-5p | PLEK2 | 2.94E-9 | PAAD |       |
 | 2q32.1 | LINC01473 | hsa-miR-370-3p | GADD45A | 1.94E-8 | PRAD |       |
 | 2q32.1 | LINC01473 | hsa-miR-370-3p | HMGA2 | 5.20E-8 | PRAD |       |
 | 2q32.1 | LINC01473 | hsa-miR-370-3p | MGMT | 5.78E-8 | PRAD |       |
 | 2q32.1 | LINC01090 | hsa-miR-145-5p | TMOD3 | 2.35E-7 | PAAD |       |
 | 2q32.1 | LINC01090 | hsa-miR-145-5p | SOX9 | 3.69E-5 | PAAD |       |
 | 2q32.1 | LINC01090 | hsa-miR-145-5p | EGFR | 5.50E-5 | PAAD |       |
 | 2q32.1 | LINC01090 | hsa-miR-193a-5p | TP73 | 6.64E-5 | PAAD |       |
 | 2q32.1 | LINC01090 | hsa-miR-145-5p | TSPAN6 | 1.03E-4 | PAAD |       |
 | 2q32.1 | LINC01473 | hsa-miR-370-3p | HMGA2 | 2.92E-4 | OV |       |
 | 2q32.1 | LINC01090 | hsa-miR-145-5p | KRT19 | 4.23E-4 | PAAD |       |
 | 2q32.1 | LINC01090 | hsa-miR-145-5p | RTKN | 6.65E-4 | KIRC |       |
 | 2q32.1 | LINC01473 | hsa-miR-370-3p | MGMT | 7.91E-4 | OV |       |
 | 2q32.1 | LINC01090 | hsa-miR-145-5p | KRT7 | 1.51E-3 | PAAD |       |
 | 2q32.1 | LINC01090 | hsa-miR-145-5p | STEAP1 | 1.60E-3 | PAAD |       |
 | 2q32.1 | LINC01090 | hsa-miR-145-5p | CTNND1 | 1.65E-3 | PAAD |       |
 | 2q32.1 | LINC01090 | hsa-miR-145-5p | AHNAK | 8.55E-3 | PAAD |       |
 | 2q32.1 | LINC01473 | hsa-miR-370-3p | GADD45A | 1.09E-2 | LUAD |       |
 | 2q32.1 | LINC01090 | hsa-miR-145-5p | CAV2 | 1.13E-2 | PAAD |       |
 | 2q32.1 | LINC01090 | hsa-miR-145-5p | KLF5 | 1.74E-2 | PAAD |       |
 | 2q32.1 | LINC01473 | hsa-miR-370-3p | FOXO1 | 3.01E-2 | LUAD |       |
 | 2q32.1 | LINC01090 | hsa-miR-145-5p | MST1R | 3.24E-2 | PAAD |       |
 | 2q32.1 | LINC01473 | hsa-miR-370-3p | FOXO1 | 4.06E-2 | LGG |       |
 | 2q32.1 | LINC01473 | hsa-miR-370-3p | MAP3K8 | 4.30E-2 | LUAD |       |